Hemophagocytic lymphohistiocytosis associated with ocrelizumab treatment in a patient with multiple sclerosis. Machlanska A, Helbig G, Chromik K, Zapala M, et al. Mult Scler 2021 Mar 5:1352458521993070. doi: 10.1177/1352458521993070.

Read + Share

Amedeo Smart

Independent Medical Education

Machlanska A, Helbig G, Chromik K, Zapala M, et al. Hemophagocytic lymphohistiocytosis associated with ocrelizumab treatment in a patient with multiple sclerosis. Mult Scler 2021 Mar 5:1352458521993070. doi: 10.1177/1352458521993070.
PMID: 33666121